Sponsor Pipeline

Neurotech Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-14 NCT06971939
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham…		 Enrollment reduced: 285 -> 234 participants
Active Trials by Phase
Phase 4
1
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06971939 Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham… Macular Telangiectasia Type 2 (MacTel) Recruiting
Phase 3
NCT06397131 A Study to Determine the Safety and Efficacy of NT-501 With MHFM Macular Telangiectasia Type 2 Active, Not Recruiting
Get alerts when Neurotech Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free